This concept presents Sam68 as a critical mediator of the Wnt/β-catenin activation state in cancer through its association with CBP, which could be harnessed in the development of selective therapeutic strategies hampering neoplastic self-renewal. The gene discussed is CREBBP; the disease is cancer.